Encompass Health Corporation (NYSE: EHC) reported Q2 EPS of $0.89, $0.07 worse than the analyst estimate of $0.96. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.34 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.